First of all he has no control of when his journal submission will be peer-reviewed. Zero influence on when. Second of all, he will reveal what data that Nader and/or the FDA will allow him to reveal during trials. Although he is not a CYDY employee, he is clearly being compensated in some way. He has made his scientific thoughts known through several interviews, including Dr. Yo. If you haven't noticed, Nader has been much more tight-lipped lately regarding research data, but other forward-moving actions suggest that the data is good. I am quite sure that if Nader wanted him there he would be there.